• Home
  • Company
    • Overview
    • Board of Directors
    • Management Team
    • Corporate Governance
    • Contact Us
  • Product Candidates
    • Product Candidates Overview
    • Cardiovascular Diseases
    • Spine Orthopedic Disorders
    • Oncology & Hematology
    • Immune-Mediated & Inflammatory Conditions
    • Clinical Trials
    • Expanded Access Policy
  • Science
    • Mesenchymal Lineage Cells
    • Mechanisms of Action
    • Manufacturing
    • Intellectual Property
    • Scientific Publications
  • Partnerships
    • Overview
  • Investors & Media
    • At A Glance
    • Company Announcements
    • Share Price & Tools
    • Events & Presentations
    • Financial Information
    • Shareholder Services
  • Careers
    • Current Opportunities
Mesoblast
Home Contact Us
  • Home
  • Company
    • Overview
    • Board of Directors
    • Management Team
    • Corporate Governance
    • Contact Us
  • Product Candidates
    • Product Candidates Overview
    • Cardiovascular Diseases
    • Spine Orthopedic Disorders
    • Oncology & Hematology
    • Immune-Mediated & Inflammatory Conditions
    • Clinical Trials
    • Expanded Access Policy
  • Science
    • Mesenchymal Lineage Cells
    • Mechanisms of Action
    • Manufacturing
    • Intellectual Property
    • Scientific Publications
  • Partnerships
    • Overview
  • Investors & Media
    • At A Glance
    • Company Announcements
    • Share Price & Tools
    • Events & Presentations
    • Financial Information
    • Shareholder Services
  • Careers
    • Current Opportunities

Scientific Publications

Mesoblast’s proprietary technologies are underscored by scientific excellence, with data reported in a wide range of peer-reviewed publications:

• Stem Cell Technology

• Cardiac and Vascular

• Orthopedic

• Immune & Inflammatory

• Oncology

• Neurologic

  • Mesenchymal Lineage Cells
    • Complementary Technologies
  • Mechanisms of Action
  • Manufacturing
  • Intellectual Property
  • Scientific Publications
    • Stem Cell Technology
    • Cardiac and Vascular
    • Orthopedic
    • Immune and Inflammatory
    • Oncology
    • Neurologic
  • Home
  • Company
    • Overview
    • Board of Directors
    • Management Team
    • Corporate Governance
    • Contact Us
  • Product Candidates
    • Product Candidates Overview
    • Cardiovascular Diseases
    • Spine Orthopedic Disorders
    • Oncology & Hematology
    • Immune-Mediated & Inflammatory Conditions
    • Clinical Trials
    • Expanded Access Policy
  • Science
    • Mesenchymal Lineage Cells
    • Mechanisms of Action
    • Manufacturing
    • Intellectual Property
    • Scientific Publications
  • Partnerships
    • Overview
  • Investors & Media
    • At A Glance
    • Company Announcements
    • Share Price & Tools
    • Events & Presentations
    • Financial Information
    • Shareholder Services
  • Careers
    • Current Opportunities
  • Copyright © 2023 Mesoblast Ltd
  • Disclaimer
  • Privacy Policy
  • Search